T&L Co. Ltd Net Assets
T&L Co. Ltd net assets. Based on the latest financial reports, T&L Co. Ltd (340570) has net assets worth ₩224.21 Billion KRW (≈ $151.94 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩253.22 Billion ≈ $171.60 Million USD) and total liabilities (₩29.01 Billion ≈ $19.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore T&L Co. Ltd (340570) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩224.21 Billion |
| % of Total Assets | 88.54% |
| Annual Growth Rate | 30.61% |
| 5-Year Change | 123.29% |
| 10-Year Change | N/A |
| Growth Volatility | 31.8 |
Net Assets of T&L Co. Ltd (2017–2025)
Net assets of T&L Co. Ltd from 2017 to 2025. This chart illustrates how T&L Co. Ltd's net assets have evolved over time, based on quarterly financial data. See 340570 equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for T&L Co. Ltd (2017–2025)
The table below shows the annual net assets of T&L Co. Ltd from 2017 to 2025. For live market cap and overall valuation, see how much is T&L Co. Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩201.16 Billion ≈ $136.32 Million |
+17.34% |
| 2024-12-31 | ₩171.44 Billion ≈ $116.18 Million |
+32.33% |
| 2023-12-31 | ₩129.55 Billion ≈ $87.80 Million |
+22.14% |
| 2022-12-31 | ₩106.07 Billion ≈ $71.88 Million |
+17.74% |
| 2021-12-31 | ₩90.09 Billion ≈ $61.05 Million |
+25.21% |
| 2020-12-31 | ₩71.95 Billion ≈ $48.76 Million |
+116.52% |
| 2019-12-31 | ₩33.23 Billion ≈ $22.52 Million |
+22.00% |
| 2018-12-31 | ₩27.24 Billion ≈ $18.46 Million |
+14.64% |
| 2017-12-31 | ₩23.76 Billion ≈ $16.10 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to T&L Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 776.9% over the analyzed period, indicating profitable operations and earnings retention.
T&L Co. Ltd Net Assets Breakdown (December 2025)
T&L Co. Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩184.86 Billion | 91.90% |
| Other Components | ₩16.30 Billion | 8.10% |
| Total Equity | ₩201.16 Billion | 100.00% |
T&L Co. Ltd Competitors by Market Cap
The table below lists competitors of T&L Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LCY Technology Corp
TW:4989
|
$255.67 Million |
|
American Realty Investors Inc
NYSE:ARL
|
$255.69 Million |
|
Beijing YJK Building Software Co.Ltd.
SHE:300935
|
$255.71 Million |
|
Shenzhen Sine Electric Co. Ltd. A
SHG:688395
|
$255.72 Million |
|
Seohee Construction Co. Ltd
KQ:035890
|
$255.64 Million |
|
Egis Technology
TWO:6462
|
$255.58 Million |
|
Ranpak Holdings Corp
NYSE:PACK
|
$255.56 Million |
|
Guangxi Hechi Chemical Co Ltd
SHE:000953
|
$255.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in T&L Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 171,436,202,680 to 201,160,254,760, a change of 29,724,052,080 (17.3%).
- Net income of 38,074,883,020 contributed positively to equity growth.
- Dividend payments of 6,054,008,250 reduced retained earnings.
- Share repurchases of 3,270,749,350 reduced equity.
- New share issuances of 663,680,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩38.07 Billion | +18.93% |
| Dividends Paid | ₩6.05 Billion | -3.01% |
| Share Repurchases | ₩3.27 Billion | -1.63% |
| Share Issuances | ₩663.68 Million | +0.33% |
| Other Changes | ₩310.25 Million | +0.15% |
| Total Change | ₩- | 17.34% |
Book Value vs Market Value Analysis
This analysis compares T&L Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.40x to 1.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩3712.52 | ₩23750.00 | x |
| 2018-12-31 | ₩4255.98 | ₩23750.00 | x |
| 2019-12-31 | ₩5192.39 | ₩23750.00 | x |
| 2020-12-31 | ₩8852.28 | ₩23750.00 | x |
| 2021-12-31 | ₩11083.81 | ₩23750.00 | x |
| 2022-12-31 | ₩13140.77 | ₩23750.00 | x |
| 2023-12-31 | ₩16049.67 | ₩23750.00 | x |
| 2024-12-31 | ₩21238.35 | ₩23750.00 | x |
| 2025-12-31 | ₩12545.65 | ₩23750.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently T&L Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.93%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.19%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 1.08x
- Recent ROE (18.93%) is below the historical average (20.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 20.21% | 18.06% | 0.79x | 1.41x | ₩2.43 Billion |
| 2018 | 17.10% | 17.69% | 0.72x | 1.34x | ₩1.93 Billion |
| 2019 | 21.93% | 22.34% | 0.75x | 1.30x | ₩3.96 Billion |
| 2020 | 13.96% | 24.71% | 0.51x | 1.10x | ₩2.85 Billion |
| 2021 | 21.74% | 27.24% | 0.73x | 1.09x | ₩10.58 Billion |
| 2022 | 19.91% | 25.89% | 0.70x | 1.10x | ₩10.51 Billion |
| 2023 | 21.18% | 23.76% | 0.81x | 1.10x | ₩14.48 Billion |
| 2024 | 27.07% | 26.54% | 0.89x | 1.15x | ₩29.26 Billion |
| 2025 | 18.93% | 23.19% | 0.76x | 1.08x | ₩17.96 Billion |
Industry Comparison
This section compares T&L Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $135,842,768,788
- Average return on equity (ROE) among peers: 9.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| T&L Co. Ltd (340570) | ₩224.21 Billion | 20.21% | 0.13x | $255.66 Million |
| Shinhung (004080) | $106.86 Billion | 7.92% | 0.32x | $91.86 Million |
| HansBiomed Corporation (042520) | $39.39 Billion | 8.88% | 0.13x | $136.42 Million |
| JVM Co. Ltd (054950) | $112.17 Billion | 9.89% | 0.57x | $188.89 Million |
| U&I Corporation (056090) | $28.54 Billion | -17.41% | 1.63x | $313.85 Million |
| Huvitz Co. Ltd (065510) | $78.48 Billion | -3.47% | 0.98x | $46.00 Million |
| Vieworks Co. Ltd (100120) | $126.17 Billion | 15.56% | 0.09x | $176.92 Million |
| Corentec Co Ltd (104540) | $56.27 Billion | -1.53% | 0.27x | $42.50 Million |
| SD Biosensor Inc (137310) | $757.55 Billion | 81.27% | 0.93x | $518.00 Million |
| Hironic Co. Ltd (149980) | $37.75 Billion | -0.69% | 0.14x | $39.75 Million |
| Humasis Co. Ltd (205470) | $15.24 Billion | -8.04% | 1.39x | $172.92 Million |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more